Owlstone Medical stock price, funding rounds, valuation and financials

Owlstone Medical has raised $66.51 m in total funding. Owlstone Medical annual revenue was £1.76 m in FY 2017

£1.8 M

Owlstone Medical Revenue FY, 2017
Owlstone Medical Revenue growth (FY, 2016 - FY, 2017), %(14%)
Owlstone Medical Gross profit (FY, 2017)1.2 M
Owlstone Medical Gross profit margin (FY, 2017), %68.2%
Owlstone Medical Net income (FY, 2017)-5.2 M
Owlstone Medical EBIT (FY, 2017)-6.2 M
Owlstone Medical Cash, 31-Dec-20171.8 M

Owlstone Medical Revenue

Owlstone Medical revenue was £1.76 m in FY, 2017 which is a 13.9% year over year decrease from the previous period.

Embed Graph

Owlstone Medical Funding

Summary Metrics

Founding Date

2004

Owlstone Medical total Funding

$66.5 m

Owlstone Medical latest funding size

$35 m

Time since last funding

a year ago

Owlstone Medical investors

Owlstone Medical's latest funding round in October 2018 was reported to be $35 m. In total, Owlstone Medical has raised $66.5 m

Owlstone Medical Revenue Breakdown

Embed Graph

Owlstone Medical revenue breakdown by business segment: 69.3% from Services and 30.7% from Product

Owlstone Medical revenue breakdown by geographic segment: 9.3% from UK, 8.3% from Rest of Europe, 79.8% from USA and 2.6% from Other

Owlstone Medical Income Statement

Annual

GBPFY, 2015FY, 2016FY, 2017

Revenue

4.4m2.0m1.8m

Revenue growth, %

(53%)(14%)

Cost of goods sold

1.6m691.0k561.7k

Gross profit

2.8m1.4m1.2m

Gross profit Margin, %

64%66%68%

Operating expense total

4.0m5.7m7.4m

EBIT

(1.2m)(4.3m)(6.2m)

EBIT margin, %

(28%)(212%)(353%)

Interest expense

8.3k6.2k169.0

Interest income

62.0750.01.1k

Pre tax profit

(1.2m)(4.3m)(6.2m)

Income tax expense

(495.7k)(671.8k)(1.0m)

Net Income

(37.7k)(3.7m)(5.2m)

Owlstone Medical Balance Sheet

Annual

GBPFY, 2015FY, 2016FY, 2017

Cash

38.2k8.1m1.8m

Accounts Receivable

165.2k411.4k470.6k

Prepaid Expenses

114.0k178.7k223.4k

Inventories

667.7k558.6k495.0k

Current Assets

1.6m10.1m4.9m

PP&E

517.6k627.9k999.6k

Total Assets

2.3m10.9m6.2m

Accounts Payable

(954.2k)(602.0k)(943.7k)

Current Liabilities

(1.8m)(1.0m)(1.4m)

Non-Current Liabilities

(60.7k)(30.2k)(20.0k)

Total Liabilities

(1.8m)(1.1m)(1.4m)

Common Stock

505.0723.0729.0

Additional Paid-in Capital

12.4m25.9m25.9m

Retained Earnings

(12.7m)(16.4m)(21.6m)

Total Equity

475.1k9.9m4.9m

Financial Leverage

4.9 x1.1 x1.3 x

Owlstone Medical Cash Flow

Annual

GBPFY, 2015FY, 2016FY, 2017

Net Income

4.4m(3.7m)(5.2m)

Depreciation and Amortization

166.0k238.1k308.3k

Accounts Receivable

175.6k(360.7k)(151.9k)

Inventories

50.0k109.1k63.6k

Accounts Payable

102.3k(734.2k)336.2k

Cash From Operating Activities

(474.3k)(4.3m)(5.5m)

Purchases of PP&E

(243.0k)(313.5k)(650.5k)

Cash From Investing Activities

(248.6k)(401.4k)(817.2k)

Cash From Financing Activities

759.8k12.7m(163.0)

Net Change in Cash

36.9k8.1m(6.3m)

Interest Paid

(8.3k)(6.2k)(169.0)

Owlstone Medical Ratios

GBPY, 2017

Revenue/Employee

24.1k

Financial Leverage

1.3 x

Owlstone Medical Operating Metrics

FY, 2016FY, 2017Mar, 2019

Clinical Trials Sites

26

Diagnostic Outcomes to Date

218 1.52 k

Patients Recruited in Clinical Trials to Date

583 1.77 k

Patients Recruited in Clinical Trials, InTERCEPT

1.40 k

Patients Recruited in Clinical Trials, LuCID

4 k

Products

4

Owlstone Medical Human Capital

Job Roles

FY, 2017FY, 2016FY, 2015
Product Research and Development 66.7 %68.1 %66.7 %
Other33.3 %31.9 %33.3 %